Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
NCT06246786
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Unable to enroll to study.
Conditions
Triple Negative Breast Cancer
DNA Damage Repair Deficiency
Interventions
DRUG:
Cyclosporin A
Sponsor
Virginia G. Kaklamani